Fehérvári Zoltán, Sakaguchi Shimon
Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Shogo-in 53, Sakyo-ku, Kyoto 606-8507, Japan.
Int Immunol. 2004 Dec;16(12):1769-80. doi: 10.1093/intimm/dxh178. Epub 2004 Nov 1.
Naturally occurring CD4+CD25+ regulatory T (TR) cells play crucial roles in normal immunohomeostasis. CD4+CD25+ TR cells exhibit a number of interesting in vitro properties including a 'default state' of profound anergy refractory to conventional T cell stimuli. We investigated the in vitro activation requirements of CD4+CD25+ TR cells using bone marrow-derived DC, which as professional antigen presenting cells (APC) can support the activation of normal naive T cells. Comparison of different APC types revealed that LPS-matured DC were by far the most effective at breaking CD4+CD25+ TR cell anergy and triggering proliferation, and importantly their IL-2 production. Examination of Foxp3, a key control gene for CD4+CD25+ TR cells, showed this to be stably expressed even during active proliferation. Although CD4+CD25+ TR cell proliferation was equivalent to that of CD25- cells their IL-2 production was considerably less. Use of IL-2-/- mice demonstrated that the DC stimulatory ability was not dependent on IL-2 production; nor did IL-15 appear crucial but was, at least in part, related to costimulation. DC also blocked normal CD4+CD25+ TR cell-mediated suppression partially via IL-6 secretion. DC therefore possess novel mechanisms to control the suppressive ability, expansion and/or differentiation of CD4+CD25+ TR cells in vivo.
天然存在的CD4+CD25+调节性T(TR)细胞在正常免疫稳态中发挥着关键作用。CD4+CD25+TR细胞表现出许多有趣的体外特性,包括对传统T细胞刺激具有深度无反应性的“默认状态”。我们使用骨髓来源的树突状细胞(DC)研究了CD4+CD25+TR细胞的体外激活需求,作为专职抗原呈递细胞(APC),DC能够支持正常幼稚T细胞的激活。不同APC类型的比较显示,脂多糖成熟的DC在打破CD4+CD25+TR细胞无反应性并触发增殖方面是迄今为止最有效的,重要的是它们能产生白细胞介素-2(IL-2)。对CD4+CD25+TR细胞的关键控制基因Foxp3的检测表明,即使在活跃增殖期间它也能稳定表达。虽然CD4+CD25+TR细胞的增殖与CD25-细胞相当,但其IL-2的产生要少得多。使用IL-2基因敲除小鼠证明,DC的刺激能力不依赖于IL-2的产生;IL-15似乎也不是关键因素,但至少部分与共刺激有关。DC还通过分泌IL-6部分阻断了正常CD4+CD25+TR细胞介导的抑制作用。因此,DC拥有控制体内CD4+CD25+TR细胞抑制能力、扩增和/或分化的新机制。